DOI:
10.1055/s-00000140
Pädiatrie up2date
LinksClose Window
References
Kremer JM, Bloom BJ, Breedveld FC. et al.
The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase II a trial of three dosage levels of CP-690,550 versus placebo.
Arthritis Rheum 2009;
60: 1895-1905
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.